Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: China Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20151
20163
20174
20183
20197
202011
20216
202217
202312
202414
202513
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status40
Recruiting35
Completed16
Active, not recruiting7
Not yet recruiting5
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital11
Fudan University8
The First Affiliated Hospital of Soochow University7
Sun Yat-sen University6
The First Affiliated Hospital with Nanjing Medical University5
BeiGene3
Beijing Tongren Hospital3
Henan Cancer Hospital3
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Shanghai Ming Ju Biotechnology Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse105
Recurrence15
Lymphoma, B-Cell7
Lymphoma, Non-Hodgkin7
Lymphoma, Follicular6
Lymphoma, Mantle-Cell5
Lymphoma3
Lymphoma, B-Cell, Marginal Zone3
Burkitt Lymphoma2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.